Five things for pharma marketers to know: Thursday, May 31, 2018

FDA approves first artificial iris; Trump expects voluntary drug price cuts; Novartis' head of oncology departs.

from Most popular articles from Medical Marketing and Media https://ift.tt/2IYemAp